Your browser doesn't support javascript.
loading
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers.
Ready, Neal; Hellmann, Matthew D; Awad, Mark M; Otterson, Gregory A; Gutierrez, Martin; Gainor, Justin F; Borghaei, Hossein; Jolivet, Jacques; Horn, Leora; Mates, Mihaela; Brahmer, Julie; Rabinowitz, Ian; Reddy, Pavan S; Chesney, Jason; Orcutt, James; Spigel, David R; Reck, Martin; O'Byrne, Kenneth John; Paz-Ares, Luis; Hu, Wenhua; Zerba, Kim; Li, Xuemei; Lestini, Brian; Geese, William J; Szustakowski, Joseph D; Green, George; Chang, Han; Ramalingam, Suresh S.
Afiliación
  • Ready N; 1 Duke University Medical Center, Durham, NC.
  • Hellmann MD; 2 Memorial Sloan Kettering Cancer Center, New York, NY.
  • Awad MM; 3 Dana-Farber Cancer Institute, Boston, MA.
  • Otterson GA; 4 The Ohio State University, Columbus, OH.
  • Gutierrez M; 5 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Gainor JF; 6 Massachusetts General Hospital, Boston, MA.
  • Borghaei H; 7 Fox Chase Cancer Center, Philadelphia, PA.
  • Jolivet J; 8 St Jerome Medical Research Inc., Saint-Jérôme, Quebec, Canada.
  • Horn L; 9 Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Mates M; 10 Kingston Health Sciences Centre, Kingston, Ontario, Canada.
  • Brahmer J; 11 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD.
  • Rabinowitz I; 12 University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
  • Reddy PS; 13 Cancer Center of Kansas, Wichita, KS.
  • Chesney J; 14 James Graham Brown Cancer Center, University of Louisville, Louisville, KY.
  • Orcutt J; 15 Charleston Hematology Oncology Associates, Charleston, SC.
  • Spigel DR; 16 Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, TN.
  • Reck M; 17 LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
  • O'Byrne KJ; 18 Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Paz-Ares L; 19 Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, CiberOnc, Madrid, Spain.
  • Hu W; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Zerba K; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Li X; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Lestini B; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Geese WJ; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Szustakowski JD; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Green G; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Chang H; 20 Bristol-Myers Squibb, Princeton, NJ.
  • Ramalingam SS; 21 Winship Cancer Institute, Emory University, Atlanta, GA.
J Clin Oncol ; 37(12): 992-1000, 2019 04 20.
Article en En | MEDLINE | ID: mdl-30785829
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Neoplasias Pulmonares / Mutación Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Nueva Caledonia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Neoplasias Pulmonares / Mutación Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Nueva Caledonia Pais de publicación: Estados Unidos